FARINA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.208
EU - Europa 1.381
AS - Asia 613
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
AF - Africa 1
SA - Sud America 1
Totale 4.218
Nazione #
US - Stati Uniti d'America 2.204
IE - Irlanda 511
CN - Cina 367
TR - Turchia 207
SE - Svezia 191
IT - Italia 168
DE - Germania 139
UA - Ucraina 126
GB - Regno Unito 113
FI - Finlandia 67
FR - Francia 39
VN - Vietnam 20
BE - Belgio 17
KR - Corea 8
EU - Europa 7
IN - India 6
AU - Australia 4
CA - Canada 4
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
HK - Hong Kong 2
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.218
Città #
Chandler 521
Dublin 511
Jacksonville 511
Izmir 100
Nanjing 96
Wilmington 83
San Mateo 79
Boardman 77
New York 76
Lawrence 67
Princeton 67
Ashburn 53
Beijing 53
Ann Arbor 52
Dearborn 42
L'aquila 41
Nanchang 37
Shenyang 31
Milan 30
Verona 27
Woodbridge 23
Hebei 22
Tianjin 21
Dong Ket 20
Falls Church 20
Seattle 18
Brussels 17
Des Moines 17
Jinan 15
Mountain View 14
Bremen 13
Jiaxing 12
Los Angeles 12
Helsinki 11
Guangzhou 10
Kunming 10
Norwalk 10
Auburn Hills 9
Changsha 9
Philadelphia 8
Hefei 7
Ningbo 7
Hangzhou 6
Impruneta 6
Taizhou 6
Washington 6
West Jordan 6
Lanzhou 5
Changchun 4
San Francisco 4
Strasbourg 4
Zhengzhou 4
Bologna 3
Catania 3
L’Aquila 3
Rome 3
Toronto 3
Altidona 2
Aquila 2
Auckland 2
Borås 2
Cambridge 2
Cava de' Tirreni 2
Cedar Knolls 2
Central 2
Chieti 2
Fairfield 2
Ferentino 2
Haikou 2
Lanciano 2
Redwood City 2
Shanghai 2
Sora 2
Taiyuan 2
Trieste 2
Amsterdam 1
Aversa 1
Bangkok 1
Belgrade 1
Berlin 1
Bratislava 1
Brisbane 1
Bucharest 1
Campobasso 1
Canberra 1
Charlotte 1
Chongqing 1
Cleveland 1
Frankfurt am Main 1
Fremont 1
Frosinone 1
Fuzhou 1
Giaveno 1
Hanover 1
Houston 1
Jakarta 1
Kadima Zoran 1
Lisbon 1
Melbourne 1
Montenero di Bisaccia 1
Totale 2.986
Nome #
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 99
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 94
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 94
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 93
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 91
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 85
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 80
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 78
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 76
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 75
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 75
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 74
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 73
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 72
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. 71
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 69
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 69
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 68
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 67
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 67
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 67
CELL-SPECIFIC BIFUNCTIONAL ROLE OF JUN ONCOGENE FAMILY MEMBERS ON GLUCOCORTICOID RECEPTOR-DEPENDENT TRANSCRIPTION 67
AN EARLY RESPONSE OF AN AP1-JUND COMPLEX DURING T-CELL ACTIVATION 66
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 65
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 65
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. 65
TrkAIII expression in the thymus 64
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 64
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 63
Alternative TrkA splicing and neuroblastoma 63
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 63
Alternative TrkAIII splicing and Cancer 62
TRASFORMING GROWTH FACTOR-BETA 1 ENHANCES THE INVASIVITY OF HUMAN MDBA-MB-231 BREAST CANCER CELLS BY UP REGULATING UROKINASE ACTIVITY 61
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 61
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 61
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 61
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 60
T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. 60
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 60
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 60
AUTOIMMUNE ANTIGEN KU IS ENRICHED ON OLIGONUCLEOTIDE COLUMNS DISTINCT FROM THOSE CONTAINING THE OCTAMER BINDING PROTEINDNA CONSENSUS SEQUENCE 59
TRANSCRIPTIONAL MODULATION OF THE HUMAN INTERCELLULAR ADHESION MOLECULE GENE I (ICAM-1) BY RETINOIC ACID IN MELANOMA CELLS 58
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 58
Alternative TrkA splicing and Cancer 56
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. 56
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 55
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 53
GLUCORTICOID RECEPTOR-MEDIATED SUPPRESSION OF THE INTERLEUKIN 2 GENE EXPRESSION THROUGH IMPAIRMENT OF THE COOPERATIVITY BETWEEN NUCLEAR FACTOR OF ACTIVATED T CELLS AND AP-1 ENHANCER ELEMENTS 51
Thioredoxin inhibits microvascular endothelial capillary tubule formation 51
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 49
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 47
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 47
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. 47
Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. 47
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 47
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 46
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 46
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 46
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 44
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 43
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 43
THE KU COMPLEX IS MODULATED IN RESPONSE TO VIRAL INFECTION AND OTHER CELLULAR CHANGES 42
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 41
PROSTAGLANDIN E2 INHIBITS THE INTERLEUKIN-2 PROMOTER ACTIVITY THROUGH DOWN-REGULATION OF THE OCT-DEPENDENT TRANSCRIPTION OF THE OCTAMER MOTIF 40
null 39
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 38
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 38
null 35
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 33
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 32
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 31
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 28
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 26
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 19
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 4
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 4
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 3
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 3
Totale 4.333
Categoria #
all - tutte 15.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019158 0 0 0 0 0 0 0 0 0 0 7 151
2019/2020626 123 0 63 8 10 84 142 19 79 23 9 66
2020/2021581 19 66 0 69 77 21 73 9 68 24 114 41
2021/2022451 33 36 73 27 26 13 12 26 23 11 35 136
2022/20231.460 94 101 35 152 133 151 3 73 649 6 32 31
2023/2024307 49 18 38 41 29 107 1 5 5 12 2 0
Totale 4.333